CDKN2B-AS1 and nasopharyngeal carcinoma: Previous studies proposed lncRNA ANRIL promoted proliferation of nasopharyngeal carcinoma cells and the expression of p14 which prevented p53 degradation was up-regulated by knockdown of lncRNA ANRIL [25, 26].